NVS

诺华制药
NYSE

实时行情|Nasdaq Last Sale

96.76
+0.47
+0.49%
盘后: 96.76 0 0.00% 16:52 02/21 EST
开盘
96.19
昨收
96.29
最高
96.96
最低
95.97
成交量
145.26万
成交额
--
52周最高
99.84
52周最低
74.97
市值
2,191.62亿
市盈率(TTM)
31.43
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NVS价格均价为102.67,最高价位105.00,最低价为100.00。

EPS

NVS 新闻

更多
  • A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
  • MotleyFool.com · 7小时前
  • Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval
  • Zacks · 11小时前
  • Dems attack Trump over stalled efforts to lower drug prices
  • Seeking Alpha - Article · 11小时前
  • Merck's Chief Digital Officer Leaves to Join Marriott
  • MotleyFool.com · 23小时前

所属板块

制药
+0.60%
制药与医学研究
+0.55%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

NVS 简况

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.
展开

微牛提供Novartis AG (ADR)(NYSE-NVS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NVS股票新闻,以帮助您做出投资决策。